Claseprubart

DRUG4 trials

Sponsors

Dianthus Therapeutics

Conditions

Chronic Inflammatory Demyelinating PolyneuropathyMultifocal Motor NeuropathyMyasthenia Gravis, Generalized

Phase 2

A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

Active, not recruitingNCT06282159

Dianthus TherapeuticsMyasthenia Gravis, Generalized

Start: 2024-02-23End: 2028-10-01Updated: 2026-07-27

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Active, not recruitingNCT06537999

Dianthus TherapeuticsMultifocal Motor Neuropathy

Start: 2024-09-17End: 2028-03-31Target: 46Updated: 2026-08-10

Phase 3

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

RecruitingNCT06858579

Dianthus TherapeuticsChronic Inflammatory Demyelinating Polyneuropathy

Start: 2025-02-10End: 2030-12-31Target: 256Updated: 2026-09-02

A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

RecruitingNCT07647510

Dianthus TherapeuticsMyasthenia Gravis, Generalized

Start: 2026-06-29End: 2031-09-01Target: 195Updated: 2026-09-01